Integra LifeSciences to Host Second Quarter 2025 Financial Results Conference Call on July 31, 2025
Integra LifeSciences (NASDAQ:IART), a leading global medical technology company, has scheduled its second quarter 2025 financial results release for Thursday, July 31, 2025, before market open. The company will host a conference call at 8:30 a.m. ET the same day to discuss the results.
Investors can access the live webcast through the company's investor relations website at investor.integralife.com. Those wishing to participate in the call must register to receive dial-in details and an individual pin. A replay of the webcast will be available on the company's website after the call.
Integra LifeSciences (NASDAQ:IART), una delle principali aziende globali nel settore della tecnologia medica, ha programmato la pubblicazione dei risultati finanziari del secondo trimestre 2025 per giovedì 31 luglio 2025, prima dell'apertura dei mercati. La società terrà una conference call lo stesso giorno alle 8:30 a.m. ET per discutere i risultati.
Gli investitori potranno seguire la diretta streaming tramite il sito web dedicato agli investitori all'indirizzo investor.integralife.com. Chi desidera partecipare alla chiamata deve registrarsi per ricevere i dettagli per la chiamata e un codice PIN personale. Una registrazione della diretta sarà disponibile sul sito web della società dopo la conclusione della call.
Integra LifeSciences (NASDAQ:IART), una empresa líder mundial en tecnología médica, ha programado la publicación de sus resultados financieros del segundo trimestre de 2025 para el jueves 31 de julio de 2025, antes de la apertura del mercado. La compañía realizará una conferencia telefónica el mismo día a las 8:30 a.m. ET para comentar los resultados.
Los inversores pueden acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de la compañía en investor.integralife.com. Aquellos que deseen participar en la llamada deben registrarse para recibir los detalles de acceso y un PIN individual. La repetición de la transmisión estará disponible en el sitio web de la empresa después de la llamada.
Integra LifeSciences (NASDAQ:IART)는 세계적인 의료 기술 선도 기업으로서, 2025년 7월 31일 목요일 장 개장 전인 2025년 2분기 재무 실적 발표를 예정하고 있습니다. 같은 날 오전 8시 30분(동부시간)에 실적 관련 컨퍼런스 콜을 진행할 예정입니다.
투자자들은 회사의 투자자 관계 웹사이트인 investor.integralife.com을 통해 생중계 웹캐스트에 접속할 수 있습니다. 콜에 참여하려면 등록하여 전화 접속 정보와 개인 PIN 번호를 받아야 합니다. 콜 종료 후 회사 웹사이트에서 웹캐스트 녹화본을 시청할 수 있습니다.
Integra LifeSciences (NASDAQ:IART), une entreprise mondiale de premier plan dans le domaine des technologies médicales, a prévu la publication de ses résultats financiers du deuxième trimestre 2025 pour le jeudi 31 juillet 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique le même jour à 8h30 ET pour discuter des résultats.
Les investisseurs peuvent accéder à la diffusion en direct via le site web des relations investisseurs de la société à investor.integralife.com. Ceux qui souhaitent participer à l'appel doivent s'inscrire pour recevoir les détails d'appel et un code PIN individuel. Une rediffusion de la diffusion sera disponible sur le site internet de la société après l'appel.
Integra LifeSciences (NASDAQ:IART), ein weltweit führendes Medizintechnikunternehmen, hat die Veröffentlichung der Finanzergebnisse für das zweite Quartal 2025 für Donnerstag, den 31. Juli 2025, vor Börsenbeginn, geplant. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Investoren können den Live-Webcast über die Investor-Relations-Website des Unternehmens unter investor.integralife.com verfolgen. Wer an dem Anruf teilnehmen möchte, muss sich registrieren, um Einwahldaten und eine persönliche PIN zu erhalten. Eine Aufzeichnung des Webcasts wird nach dem Anruf auf der Website des Unternehmens verfügbar sein.
- None.
- None.
PRINCETON, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2025 financial results on Thursday, July 31, 2025, prior to the market open. In conjunction with the earnings release, Integra’s management team will host a conference call at 8:30 a.m. ET.
A live webcast will be available on the Investors section of the Company’s website at investor.integralife.com. For those planning to participate on the call, register here to receive dial-in details and an individual pin. While not required, joining 10 minutes before the event starts is recommended. A webcast replay of the conference call will be available on the Investors section of the Company’s website following the call.
About Integra LifeSciences
At Integra LifeSciences, we are driven by our purpose of restoring patients’ lives. We innovate treatment pathways to advance patient outcomes and set new standards of surgical, neurologic and regenerative care. We offer a comprehensive portfolio of high quality, leadership brands. For the latest news and information about Integra and its products, please visit www.integralife.com.
Investor Relations:
Chris Ward
(609) 772-7736
chris.ward@integralife.com
Media Contact:
Laurene Isip
(609) 208-8121
laurene.isip@integralife.com
FAQ
When will Integra LifeSciences (IART) release Q2 2025 earnings?
What time is Integra LifeSciences Q2 2025 earnings call?
How can I access Integra LifeSciences Q2 2025 earnings call?
Will there be a replay of Integra LifeSciences Q2 2025 earnings call?
